eli lilly news glp-1 GLP-1 demand boom continues as Eli Lilly soars on strong quarter

Eli Lilly's oral GLP-1 pill may help people with Type 2 diabetes lose 'significant' weight, study finds

24.45

★★★★☆4.8 (126)

The FDA approved a new GLP-1 pill from Eli Lilly on Wednesday. The drug, called Foundayo, is the second GLP-1 weight-loss pill. CBS News' Dr. LaPook has more on the new medication

26.46

★★★★★4.9 (98)

New clinical trial data from Eli Lilly shows its GLP-1 daily weight loss pill can reduce body weight by up to 11% over time. ABC News medical correspondent Dr. Darien Sutton joins Linsey Davis to

25.35

★★★★★5.0 (157)

Eli Lilly jumps on GLP-1 pill trial success

21.91

★★★★★4.7 (84)

The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications

28.23

★★★★★4.9 (203)

FDA just approved orforglipron (Foundayo), Eli Lilly's oral GLP-1 receptor agonist for obesity. In the ATTAIN-1 phase 3 trial (n=3,127), published in the New England Journal of Medicine, patients on the highest

20.68

★★★★★5.0 (176)

Lilly warns GLP-1 knockoffs may be 'dangerous,' escalating war with compounders

23.18

★★★★★4.8 (132)